查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1635339

美国药品合约包装：市场占有率分析、行业趋势和成长预测（2025-2030）

US Pharmaceutical Contract Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

美国药品合约包装市场预计在预测期内复合年增长率为 8.78%。

美国药品合约包装-市场-IMG1

主要亮点

  • 合约包装为製药公司提供了使其产品在竞争中脱颖而出的机会。药品包装的差异化通常着重于使用者需求和使用案例。例如，特定指示要求部分就是合约包装的此类需求之一。
  • 此外，系列化仍然是医疗设备、装置、植入式设备以及管瓶和注射器等消耗品的柔性无菌包装的驱动因素。对口服药物、处方剂量药物和非处方药 (OTC) 药物管理的需求不断增长，预计将增加柔性铝箔在製药领域的使用。
  • 此外，根据人类资料科学公司 IQVIA 的数据，全球药品销售额预计将从 2019 年的 4,910 亿美元增至 2023 年的 1.5 兆美元。美国在医药产业的消费和开发方面均占据主导地位。根据 STAT 的数据，该国处方药支出预计将在 2023 年达到 6,000 亿美元，高于 2019 年估计的 5,000 亿美元。
  • 由于 COVID-19 对管瓶、药品和其他产品的需求产生了重大影响，该行业的製造商已争夺资源并推动加速製造和包装程序。亚太地区的供应链问题不仅对医药原料至关重要，对包装产业原料至关重要，导致疫情爆发初期几个月，CMO 和 CPO 市场均出现严重材料短缺，导致大量材料短缺。出现短缺。

美国药品合约包装市场趋势

大型製药企业外包数量增加

  • 将救生药品委託外包给值得信赖的服务供应商的竞争正在加速，尤其是在新冠肺炎 (COVID-19) 大流行期间，成本控製成为当务之急，同时还面临着以前无法想像的其他业务中断的威胁。
  • 此外，药物开发和製造是一项资本密集型业务。随着学名药净利率下降，製造商正在缩减对该类别的投资。透过外包包装系统，公司可以在与包装专家合作的同时降低药品包装成本。
  • 为了满足不断增长的市场需求，2021 年 10 月，服务于製药业的美国合约包装公司 Tjoapack 宣布收购了位于田纳西州克林顿的领先医疗保健包装服务提供商 Pharma Packaging Solutions。 Tjoapack 对 PPS 的收购创造了一个机会，为製药市场打造合约包装和供应链服务领域新的全球领导者。此次收购支持了 Tjoapack 的成长策略，并体现了我们对客户的承诺。

泡壳包装占据最高市场占有率

  • 泡壳包装主要用于保护产品免受湿气、气体、光线和温度的影响，并延长其保质期。泡壳包装有助于保持产品完整性，因为泡壳包装的药品可以免受不利条件的影响。泡壳包装主要用于包装成药、药品（胶囊）、小型医疗设备等药品。
  • 製药业不断增长的需求是北美地区泡壳包装需求的主要驱动力之一。 FDA 法规的实施要求医院和疗养院配发的所有处方笺药均以带有条码的单位剂量形式包装，以减少配发错误，这也增加了近年来 Masu泡壳的销量。
  • 在美国，泡壳包装用于非处方笺柜檯后面的产品，例如过敏药物和口香糖。在处方药包装方面，美国零售商和消费者正在追赶世界其他地区。国内对泡壳包装的需求不断增加。
  • 美国医药市场是全球最重要的国内市场之一。光是美国就占全球医药市场的45%以上。该国预计每年在药物研发上花费近600亿美元。
  • 製药公司对药品安全和包装有效性有严格的政策，这导致泡壳包装等药品包装的增加，这积极促进了市场的成长。

美国药品合约包装产业概况

美国药品包装市场竞争激烈，由多家大公司组成。从市场占有率来看，目前少数大公司占据市场主导地位。然而，处方药和疫苗的广泛采用正在增加市场需求。许多公司透过赢得新契约和开发新市场来扩大其市场份额。

  • 2021 年 12 月 - 製药和营养保健品行业的国际契约製造公司 KD Pharma Group 最近宣布收购了总部位于瑞士的化学品製造商前 Rohner AG 的製造资产。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 买家/消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度
  • COVID-19 市场影响评估
  • 市场驱动因素
    • 外包的成本效益
    • 获得尖端技术和专业知识
  • 市场限制因素
    • 监控问题和缺乏标准化

第五章市场区隔

  • 按服务类型
    • 基本的
      • 医疗袋
      • 泡壳包装
      • 药筒和注射器
      • 管瓶
      • 安瓿
      • 其他产品类型
    • 中学
    • 第三
  • 依材料类型
    • 塑胶
    • 纸板
    • 玻璃

第六章 竞争状况

  • 公司简介
    • Thermo-Pak Co., Inc.
    • Aphena Pharma Solutions
    • Sonic Packaging Industries, Inc.
    • Assemblies Unlimited, Inc.
    • Action Pak, Inc.
    • AmeriPac, Inc.
    • MBK Tape Solutions
    • Elitefill, Inc.
    • Tru Body Wellness
    • Deluxe Packaging

第七章 市场机会及未来趋势

简介目录
Product Code: 91407

The US Pharmaceutical Contract Packaging Market is expected to register a CAGR of 8.78% during the forecast period.

US Pharmaceutical Contract Packaging - Market - IMG1

Key Highlights

  • Contract packaging gives pharmaceutical companies a chance to differentiate their product against the competition. Differentiation in pharmaceutical packaging is usually focused on the user's needs and use case. For example, the specific indication requirements section is one such need for contract packaging.
  • Further, Serialization continues to be a driving factor for flexible, sterile packaging used for medical equipment, devices, implantable devices, and consumables, such as vials and syringes, among others. Increased demand for administering oral drugs, prescription dose medicines, and over-the-counter (OTC) medicines is expected to increase the use of flexible aluminum foil in the pharmaceutical sector.
  • Furthermore, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical sector, both in consumption and development. According to STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019.
  • Manufacturers in the sector rushed their resources and pushed for quicker manufacturing and packaging procedures as a result of COVID-19's considerable impact on the demand for vials, medications, and other products. Due to supply chain issues in the Asia-Pacific region, which holds a prominent position when it comes to pharmaceutical raw materials as well as packaging industry raw materials, there was a significant shortage of materials for both CMOs and CPOs in the market during the early months of the pandemic, which caused slower manufacturing and packaging.

US Pharmaceutical Contract Packaging Market Trends

Increasing Outsourcing Volumes by Major Pharmaceutical Companies

  • With cost containment a priority, especially in the era of the COVID-19 pandemic and the threat of other previously unimagined business disruptions, the race to contract packaging of life-saving drugs for trusted service providers is accelerating.
  • Also, the development and manufacturing of medications is a capital-intensive business. With margins shrinking for generics, manufacturers are reducing the scale of their investments within this category. Outsourcing the packaging mechanism enables companies to work with packaging experts while reducing the packaging expenses of the drugs.
  • Owing to the increasing demand in the market, in October 2021, Tjoapack, a Netherlands-based contract packaging organization serving the pharmaceutical industry, acquired US-based Pharma Packaging Solutions ("PPS"), a leading healthcare packaging services business based in Clinton, TN. Tjoapack's acquisition of PPS creates an opportunity to build a new global leader in contract packaging and supply chain services for the pharmaceutical market. The acquisition supports Tjoapack's growth strategy and is indicative of our commitment to customers

Blister Packs to Hold the Highest Market Share

  • Blister packaging is mostly used to provide barrier protection from moisture, gas, light, and temperature and longer shelf life. Blister packaging helps retain product integrity as drugs that are pre-packed in blisters are shielded from adverse conditions. Blister packs are mainly used for packaging pharmaceutical products, such as OTC drugs and medicines (capsules), and small medical devices.
  • The growing demand for the pharmaceutical industry is one of the primary drivers of the blister packaging demand in the North American region. The implementation of FDA regulations that require that all prescribed pharmaceuticals that are dispensed in hospitals and nursing homes are to be packaged in unit-dose formats, including barcodes to reduce dispensing errors, has also increased the sales of blister packs over the past few years.
  • In the United States, blister packaging is used for products that are not behind the prescription counter, such as allergy medication or chewing gum. The US retailers and consumers are catching up with the rest of the world when it comes to packaging prescribed medications. The demand for blister packaging is increasing in the country.
  • The US pharmaceutical market is among the world's most important national markets. The United States alone holds over 45% of the global pharmaceutical market. It is expected that almost USD 60 billion is spent annually on pharmaceutical R&D purposes in the country.
  • Pharmaceutical companies are stringent about their policies regarding drug safety and effectiveness of drug packaging, and this, in turn, is leading to an increase in pharmaceutical packaging such as blister packs, thereby, driving the market's growth positively.

US Pharmaceutical Contract Packaging Industry Overview

The United States Pharmaceutical Packaging market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with extensive adoption of prescription drugs and vaccines is increasing the demand in the market. Many companies are increasing their market presence by securing new contracts and by tapping new markets.

  • December 2021 - KD Pharma Group, an international contract manufacturer for the pharmaceutical and nutraceutical industries, announced recently that it has acquired the manufacturing assets of the former Rohner AG, a chemical manufacturer based in Switzerland.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness-Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers/Consumers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Assessment of COVID-19 Impact on the market
  • 4.4 Market Drivers
    • 4.4.1 Cost-Effectiveness Of The Outsourcing
    • 4.4.2 Access to the advanced technologies and expertise
  • 4.5 Market Restraints
    • 4.5.1 Monitoring issues and lack of standardization

5 MARKET SEGMENTATION

  • 5.1 Service Type
    • 5.1.1 Primary
      • 5.1.1.1 Medical Pouches
      • 5.1.1.2 Blister Packs
      • 5.1.1.3 Cartridges and Syringes
      • 5.1.1.4 Vials
      • 5.1.1.5 Ampoules
      • 5.1.1.6 Others Product Types
    • 5.1.2 Secondary
    • 5.1.3 Tertiary
  • 5.2 Material Type
    • 5.2.1 Plastic
    • 5.2.2 Paper & Paperboard
    • 5.2.3 Glass

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo-Pak Co., Inc.
    • 6.1.2 Aphena Pharma Solutions
    • 6.1.3 Sonic Packaging Industries, Inc.
    • 6.1.4 Assemblies Unlimited, Inc.
    • 6.1.5 Action Pak, Inc.
    • 6.1.6 AmeriPac, Inc.
    • 6.1.7 MBK Tape Solutions
    • 6.1.8 Elitefill, Inc.
    • 6.1.9 Tru Body Wellness
    • 6.1.10 Deluxe Packaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS